Clinical trial
Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in…
NCT00002977 · Fred Hutchinson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00002977 |
|---|---|
| Title | Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete Remission |
| Official title | A Phase I Trial of Melphalan and Thiotepa Followed by Autologous or Syngeneic Peripheral Blood Stem Cell (PBSC) Rescue in Patients With a Complete Response Following Standard Therapy for Stage III/IV Epithelial Ovarian Cancer |
| Lead sponsor | Fred Hutchinson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Ovarian Cancer |
| Intervention type | Biological, Drug, Procedure |
| Interventions | filgrastim, melphalan, thiotepa, peripheral blood stem cell transplantation |
| Enrollment | 45 |
| Start date | Jan 1, 1997 |
| Primary completion | Nov 1, 2001 |
| First posted | Apr 29, 2004 |
| Last update posted | Sep 15, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: